Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064
Clinical trial NCT03918980 · COMPLETED
Trial details
- NCT number
- NCT03918980
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-18
- Primary completion
- 2020-01-27
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.